Peregrine Pharmaceuticals, Inc.( PPHM) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Peregrine Pharmaceuticals, Inc.( PPHM)

An SI Board Since November 2000

Posts	SubjectMarks	Bans	Symbol
3795	72	0	PPHM

Emcee: Terry D.	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
3595	And another investigation by a law firm. We had better hope that Tustin didn'	Terry D.	-	9/25/2012
3594	That's clueless (eom). You and I finally agree on something. :-) (But PP	The Dodgy Ticker	-	9/25/2012
3593	yep, told you that coming next, smelling the blood.	rjk01	-	9/25/2012
3592	That's clueless (eom).	DewDiligence_on_SI	-	9/25/2012
3591	"A subsequent review of information has determined that the source of thes	Terry D.	-	9/25/2012
3590	Are you saying the FDA was in cahoots with some BP to sabotage the results of th	Terry D.	-	9/25/2012
3589	HELLOO, Did it ever occur to anyone that maybe the FDA is under a lot of pressur	clayton3	-	9/25/2012
3588	I can't wait for the next dog and pony show. Bronstein, Gewirtz & Gros	Terry D.	-	9/25/2012
3587	just think about the litigation. i think we are doomed for good this time.......	rjk01	1	9/24/2012
3586	hate to say i told you so, cant trust those guys and sell at every HYPE. Fri was	rjk01	1	9/24/2012
3585	I seem to recall we went through this same BS with Cambridge Antibody Technology	Terry D.	-	9/24/2012
3584	Peregrine Pharma down 86% after test data review marketwatch.com	Glenn Petersen	-	9/24/2012
3583	Abstract on the diffferent targets of different TNT MABs. [131I]-TNT-1 Khawli	Terry D.	-	9/21/2012
3582	already noted? First AT001/r84 Dose in Man in Clinical Trial in Russia Sourc	Terry D.	-	9/21/2012
3581	Bavituximab: New Targeted Therapy Shows Promising Survival Benefit in Phase II N	Terry D.	-	9/19/2012
3580	Motley Fool actually mentioned us in a somewhat positive manner. But Threshold	Terry D.	-	9/17/2012
3579	I wanted to see how our NSCLC trial stacked up against other trials both in enro	Terry D.	-	9/13/2012
3578	Thanks for the reply. I haven't been reading many posts lately. I went into	Terry D.	-	9/12/2012
3577	Thanks, Tuck......appreciate your input. Bob	The Dodgy Ticker	-	9/12/2012
3576	This issue is being flogged to death over on IHub on the "Biotech Values&qu	tuck	-	9/12/2012
3575	the q is how bad it will go south this time and how soon they can generate news	rjk01	-	9/11/2012
3574	RE "the current long suffering shareholders will be diluted into oblivion&q	EACarl	-	9/11/2012
3573	A question for the mathematicians. Was the number of patients in the NSCLC trial	Terry D.	-	9/11/2012
3572	i used to play it years ago......actually bought down from .9 to .5 just this ye	rjk01	-	9/11/2012
3571	I haven't even bothered listening to the CC. I figured it would be more of t	Terry D.	-	9/11/2012

Go to reply# or date (mm/dd/yy):